Satyanarayana Rachagani

Provider placeholder

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

Research & Select Publications

Characterization of a bronchoscopically induced transgenic lung cancer pig model for human translatability
Authors:

Joshi K, Suvilesh KN, Natesh NS, one or more additional authors omitted Rachagani S

Journal & Year:

Lab Anim (NY) | 2026

Functional significance of the aryl hydrocarbon receptor in oncogenic signaling pathways
Authors:

Arciga BM, Katepalli A, Natesh NS, one or more additional authors omitted Rachagani S

Journal & Year:

Carcinogenesis | 2025

Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition
Authors:

Nethi SK, Gunda V, Natesh NS, one or more additional authors omitted Rachagani S

Journal & Year:

iScience | 2025

The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
Authors:

Thulasinathan B, Suvilesh KN, Maram S, one or more additional authors omitted Rachagani S

Journal & Year:

Gut Microbes | 2025

Characterization of A Bronchoscopically Induced Transgenic Lung Cancer Pig Model for Human Translatability
Authors:

Kaifi J, Joshi K, Suvilesh K, one or more additional authors omitted Rachagani S

Journal & Year:

Res Sq | 2025

Pulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors
Authors:

Arciga BM, Walters DM, Kimchi ET, one or more additional authors omitted Rachagani S, Kaifi JT

Journal & Year:

Cancer Lett | 2025

Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer
Authors:

White BM, Gunda V, Nethi SK, one or more additional authors omitted Rachagani S

Journal & Year:

Regen Eng Transl Med | 2025

Characterization of A Bronchoscopically Induced Transgenic Lung Cancer Pig Model for Human Translatability
Authors:

Joshi K, Suvilesh KN, Natesh NS, one or more additional authors omitted Rachagani S

Journal & Year:

bioRxiv | 2024

Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non-Small Cell Lung Cancer Patient-Derived Tumor Organoids
Authors:

Suvilesh KN, Manjunath Y, Nussbaum YI, one or more additional authors omitted Rachagani S, Kaifi JT

Journal & Year:

Clin Cancer Res | 2024

Pigs: Large Animal Preclinical Cancer Models
Authors:

Joshi K, Katam T, Hegde A, one or more additional authors omitted Rachagani S

Journal & Year:

World J Oncol | 2024

Benefits and opportunities of the transgenic Oncopig cancer model
Authors:

Joshi K, Telugu BP, Prather RS, one or more additional authors omitted Rachagani S

Journal & Year:

Trends Cancer | 2024